Form 4: Boundless Bio Executive Jessica Oien Reports Stock Option Grant

Jessica Oien, Chief Legal Officer and Corporate Secretary of Boundless Bio, Inc., reported the acquisition of stock options.

Summary

• Jessica Oien, Chief Legal Officer and Corporate Secretary of Boundless Bio, Inc. (BOLD), filed a Form 4 on March 29, 2024, reporting a transaction.
• The transaction involved the acquisition of 16,234 stock options on March 27, 2024, with an exercise price of $16.
• These options vest in 48 equal monthly installments starting April 27, 2024, and expire on March 26, 2034.
• Following the reported transaction, Oien directly owns 16,234 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently indicate positive or negative sentiment, but rather reports a standard executive compensation practice.

Positives

• The grant of stock options to a key executive aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates compensation for a key executive.

Stakeholder Impact

• The stock option grant aligns the executive's interests with those of the shareholders, potentially incentivizing them to increase shareholder value.

Key Dates